Bone Marrow TransplantationBone MarrowTransplantation, HomologousBone Marrow CellsGraft vs Host DiseaseTransplantation, AutologousAntineoplastic Combined Chemotherapy ProtocolsWhole-Body IrradiationBone and BonesHematopoietic Stem Cell TransplantationTransplantation ConditioningAnemia, AplasticLeukemiaLiver TransplantationTransplantation ChimeraCyclophosphamideHematopoietic Stem CellsGraft SurvivalTissue DonorsBusulfanCombined Modality TherapyBone Marrow PurgingHistocompatibility TestingTreatment OutcomeStem CellsHistocompatibilityBone Marrow DiseasesTransplantation, IsogeneicStem Cell TransplantationRecurrenceHematopoiesisKidney TransplantationLeukemia, Myeloid, AcuteMice, Inbred C57BLTime FactorsRadiation ChimeraLeukemia, Myelogenous, Chronic, BCR-ABL PositivePrecursor Cell Lymphoblastic Leukemia-LymphomaBone Marrow ExaminationSurvival AnalysisHematologic NeoplasmsImmunosuppressive AgentsLymphoma, Non-HodgkinRemission InductionHepatic Veno-Occlusive DiseaseGraft RejectionChemotherapy, AdjuvantLeukemia, MyeloidBone RemodelingBone Marrow NeoplasmsTransplantation ImmunologyGraft vs Host ReactionAcute DiseaseDisease-Free SurvivalImmunosuppressionLymphocyte DepletionSurvival RateEtoposideLeukocyte TransfusionHeart TransplantationColony-Forming Units AssayMyelodysplastic SyndromesSevere Combined ImmunodeficiencyChimeraT-LymphocytesActuarial AnalysisHematologic DiseasesFollow-Up StudiesCytarabineCarmustineHLA AntigensPrognosisRetrospective StudiesGranulocyte Colony-Stimulating FactorLung TransplantationAntineoplastic AgentsCyclosporineBone DensityLymphocyte TransfusionMelphalanCell DifferentiationNuclear FamilyLeukocyte CountMethotrexatePancytopeniaLymphomaOrgan TransplantationHodgkin DiseaseGraft vs Tumor EffectFlow CytometryGraft vs Leukemia EffectMultiple MyelomaMice, Inbred BALB CCells, CulturedCytomegalovirus InfectionsDoxorubicinSpleenFatal OutcomeBone ResorptionAntigens, CD34